vs
Side-by-side financial comparison of FENNEC PHARMACEUTICALS INC. (FENC) and YORK WATER CO (YORW). Click either name above to swap in a different company.
YORK WATER CO is the larger business by last-quarter revenue ($19.4M vs $13.8M, roughly 1.4× FENNEC PHARMACEUTICALS INC.). YORK WATER CO runs the higher net margin — 26.7% vs -34.7%, a 61.4% gap on every dollar of revenue. On growth, FENNEC PHARMACEUTICALS INC. posted the faster year-over-year revenue change (73.8% vs 3.2%). Over the past eight quarters, YORK WATER CO's revenue compounded faster (5.1% CAGR vs -26.3%).
Fennec Pharmaceuticals Inc. is a biopharmaceutical firm focused on developing and commercializing therapies to reduce treatment-related side effects in pediatric cancer patients. Its lead product targets chemotherapy-induced ototoxicity, with core North American markets serving oncology providers and vulnerable pediatric patient groups.
The York Water Company is an investor-owned, public utility company based in York, Pennsylvania and operating throughout Pennsylvania. The company was founded in 1816 by a group of local businessmen concerned about fire protection.
FENC vs YORW — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $13.8M | $19.4M |
| Net Profit | $-4.8M | $5.2M |
| Gross Margin | — | — |
| Operating Margin | -18.5% | 33.2% |
| Net Margin | -34.7% | 26.7% |
| Revenue YoY | 73.8% | 3.2% |
| Net Profit YoY | -141.1% | 0.5% |
| EPS (diluted) | $-0.17 | $0.36 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $13.8M | $19.4M | ||
| Q3 25 | $12.5M | $20.2M | ||
| Q2 25 | $9.7M | $19.1M | ||
| Q1 25 | $8.8M | $18.3M | ||
| Q4 24 | $7.9M | $18.8M | ||
| Q3 24 | $7.0M | $19.6M | ||
| Q2 24 | $7.3M | $18.6M | ||
| Q1 24 | $25.4M | $17.5M |
| Q4 25 | $-4.8M | $5.2M | ||
| Q3 25 | $-638.0K | $6.2M | ||
| Q2 25 | $-3.2M | $5.1M | ||
| Q1 25 | $-1.2M | $3.6M | ||
| Q4 24 | $-2.0M | $5.1M | ||
| Q3 24 | $-5.7M | $5.9M | ||
| Q2 24 | $-5.6M | $5.0M | ||
| Q1 24 | $12.8M | $4.3M |
| Q4 25 | -18.5% | 33.2% | ||
| Q3 25 | -1.5% | 39.1% | ||
| Q2 25 | -28.3% | 37.1% | ||
| Q1 25 | -9.2% | 34.3% | ||
| Q4 24 | -11.8% | 35.8% | ||
| Q3 24 | -74.6% | 41.1% | ||
| Q2 24 | -69.4% | 37.9% | ||
| Q1 24 | 54.2% | 35.5% |
| Q4 25 | -34.7% | 26.7% | ||
| Q3 25 | -5.1% | 30.6% | ||
| Q2 25 | -32.7% | 26.5% | ||
| Q1 25 | -13.3% | 19.8% | ||
| Q4 24 | -25.0% | 27.4% | ||
| Q3 24 | -82.2% | 29.9% | ||
| Q2 24 | -76.5% | 26.8% | ||
| Q1 24 | 50.6% | 24.7% |
| Q4 25 | $-0.17 | $0.36 | ||
| Q3 25 | $-0.02 | $0.43 | ||
| Q2 25 | $-0.11 | $0.35 | ||
| Q1 25 | $-0.04 | $0.25 | ||
| Q4 24 | $-0.02 | $0.36 | ||
| Q3 24 | $-0.21 | $0.41 | ||
| Q2 24 | $-0.20 | $0.35 | ||
| Q1 24 | $0.41 | $0.30 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $36.8M | $1.0K |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $35.5M | $240.3M |
| Total Assets | $70.6M | $680.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $36.8M | $1.0K | ||
| Q3 25 | $21.9M | $1.0K | ||
| Q2 25 | $18.7M | $1.0K | ||
| Q1 25 | $22.7M | $1.0K | ||
| Q4 24 | $26.6M | $1.0K | ||
| Q3 24 | $40.3M | $1.0K | ||
| Q2 24 | $43.1M | $1.0K | ||
| Q1 24 | $51.2M | $3.3M |
| Q4 25 | — | — | ||
| Q3 25 | $19.4M | — | ||
| Q2 25 | $19.4M | — | ||
| Q1 25 | $19.4M | — | ||
| Q4 24 | $19.3M | — | ||
| Q3 24 | $32.1M | — | ||
| Q2 24 | $31.8M | — | ||
| Q1 24 | $31.3M | — |
| Q4 25 | $35.5M | $240.3M | ||
| Q3 25 | $-4.5M | $238.0M | ||
| Q2 25 | $-7.5M | $234.6M | ||
| Q1 25 | $-5.9M | $232.1M | ||
| Q4 24 | $-5.9M | $231.2M | ||
| Q3 24 | $-5.2M | $228.7M | ||
| Q2 24 | $-1.4M | $225.4M | ||
| Q1 24 | $3.0M | $222.9M |
| Q4 25 | $70.6M | $680.9M | ||
| Q3 25 | $49.3M | $667.1M | ||
| Q2 25 | $44.9M | $653.7M | ||
| Q1 25 | $46.4M | $641.8M | ||
| Q4 24 | $44.9M | $633.5M | ||
| Q3 24 | $58.9M | $621.4M | ||
| Q2 24 | $63.2M | $610.4M | ||
| Q1 24 | $69.2M | $602.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 10.40× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-6.0M | $8.4M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | 1.63× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-6.0M | $8.4M | ||
| Q3 25 | $1.5M | $7.8M | ||
| Q2 25 | $-3.7M | $7.6M | ||
| Q1 25 | $-4.3M | $6.0M | ||
| Q4 24 | $-1.5M | $10.2M | ||
| Q3 24 | $-2.2M | $7.5M | ||
| Q2 24 | $-8.4M | $6.7M | ||
| Q1 24 | $39.0M | $6.1M |
| Q4 25 | — | 1.63× | ||
| Q3 25 | — | 1.26× | ||
| Q2 25 | — | 1.50× | ||
| Q1 25 | — | 1.65× | ||
| Q4 24 | — | 1.98× | ||
| Q3 24 | — | 1.29× | ||
| Q2 24 | — | 1.34× | ||
| Q1 24 | 3.04× | 1.42× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
